As COVID-19 continues to evolve, new variants occasionally capture public attention. One of the latest to be closely monitored is BA.3.2, informally nicknamed the “Cicada” variant. While the name may sound alarming, health experts emphasize that this variant is not currently associated with more severe illness than other recent Omicron descendants.
Still, BA.3.2 is worth understanding because it appears to carry a large number of mutations and may have a greater ability to evade immunity from prior infection or vaccination. For individuals, employers, schools, and healthcare providers, this reinforces the importance of staying informed and testing promptly when symptoms appear.
At My Care Labs, we continue to provide fast, accurate COVID-19 testing with walk-in appointments, insurance and cash-pay options, and mobile testing services for workplaces and community groups. Whether you need individual testing or large-scale screening, our goal is to make high-quality diagnostics convenient and accessible.
What Is the BA.3.2 “Cicada” Variant?
BA.3.2 is a sublineage of the Omicron family of SARS-CoV-2, the virus that causes COVID-19. The nickname “Cicada” is an informal media term inspired by the way the lineage appeared to circulate quietly for an extended period before gaining renewed attention. It is not an official name used by organizations such as the World Health Organization (WHO).
BA.3.2 was first identified in late 2024 and was later designated by the WHO as a Variant Under Monitoring (VUM). This designation means scientists are tracking it closely due to its genetic changes, but there is no evidence at this time that it poses a substantially greater public health threat than other circulating variants.
Why Is BA.3.2 Getting Attention?
The main reason BA.3.2 is being monitored is the unusually high number of mutations in its spike protein—the part of the virus targeted by antibodies.
Researchers estimate BA.3.2 carries 70–75 spike protein changes, which may help it partially evade immune defenses. However, immune escape does not automatically mean more severe disease. Current evidence suggests that protection against hospitalization and severe outcomes remains strong, especially for people who are up to date on vaccination.
Is the Cicada Variant More Dangerous?
At this time, there is no evidence that BA.3.2 causes more severe illness, hospitalizations, or deaths compared with other Omicron variants.
Experts describe BA.3.2 as a variant that may be better at infecting people who already have some immunity, but not necessarily more harmful once infection occurs. This pattern is consistent with the way SARS-CoV-2 has evolved over time.
For most people, the practical takeaway is straightforward:
- Stay up to date with recommended vaccines
- Test when symptoms develop
- Isolate when appropriate
- Seek treatment early if you are at high risk
Common Symptoms of BA.3.2
Symptoms of the Cicada variant appear similar to those seen with other Omicron strains.
Common symptoms include:
- Sore throat
- Runny or stuffy nose
- Cough
- Fever or chills
- Fatigue
- Headache
- Muscle aches
- Mild shortness of breath
- Nausea in some cases
Because these symptoms overlap with flu, RSV, and the common cold, testing remains the most reliable way to confirm infection.
How Contagious Is BA.3.2?
BA.3.2 appears to spread efficiently and may cause reinfections due to its immune-evasive mutations. However, its real-world growth advantage over other circulating strains is still being studied.
Scientists note that some of its mutations may help it avoid antibodies, while others may reduce how efficiently it binds to human cells. This balance may limit its overall impact.
Can Current Vaccines Still Help?
Yes. Updated COVID-19 vaccines are still expected to provide meaningful protection against severe disease, hospitalization, and death caused by BA.3.2.
Even if a variant can partially evade antibodies, other components of the immune system—particularly T cells—continue to provide important protection against severe outcomes.
Vaccination remains especially important for:
- Adults 65 and older
- Immunocompromised individuals
- People with chronic medical conditions
- Healthcare workers
Why COVID Testing Still Matters
As new variants emerge, symptoms alone are often not enough to distinguish COVID-19 from other respiratory illnesses.
Testing helps you:
- Confirm infection quickly
- Begin treatment within the recommended window
- Protect family members and coworkers
- Meet workplace or school requirements
- Make informed decisions about isolation and travel
Prompt testing is especially important for high-risk individuals who may benefit from antiviral treatment.
Fast and Accurate COVID Testing at My Care Labs
At My Care Labs, we provide dependable laboratory testing to help individuals and organizations respond quickly to changing COVID trends.
Our COVID Testing Services Include:
- PCR COVID-19 testing
- Rapid antigen testing
- COVID and flu combination testing
- Respiratory pathogen panels
- Pre-travel testing
- Workplace screening programs
Why Patients and Employers Choose My Care Labs:
- Fast turnaround times
- Walk-in availability
- Insurance and cash-pay options
- Mobile testing services
- Group and B2B testing programs
Whether you are managing symptoms, screening employees, or planning travel, our team is committed to delivering accurate results you can trust.
Mobile COVID Testing for Businesses and Organizations
For employers, schools, and community groups, mobile testing offers a convenient way to test multiple individuals without disrupting daily operations.
Our mobile services are ideal for:
- Corporate offices
- Schools and universities
- Healthcare facilities
- Long-term care communities
- Events and conferences
Benefits include:
- On-site specimen collection
- Reduced employee downtime
- Faster response to outbreaks
- Flexible scheduling
COVID and Flu Testing: Why Dual Testing Is Valuable
Many respiratory illnesses share similar symptoms, making it difficult to know which virus is responsible.
COVID and flu combination testing can help:
- Identify the cause of illness
- Guide treatment decisions
- Reduce unnecessary isolation
- Improve return-to-work decisions
This is especially useful during periods when multiple viruses are circulating.
When Should You Get Tested?
Consider COVID testing if you:
- Develop symptoms such as sore throat, cough, or fever
- Have close contact with someone who tested positive
- Need clearance for work, school, or travel
- Are at high risk and may need treatment
- Want confirmation before visiting vulnerable family members
Testing as soon as symptoms begin can improve decision-making and treatment timing.
How Employers Can Respond to New Variants
Businesses do not need to panic when a new variant appears, but they should remain prepared.
Best practices include:
- Encouraging sick employees to stay home
- Providing access to testing
- Maintaining clear return-to-work policies
- Supporting vaccination efforts
- Using mobile testing during outbreaks
My Care Labs partners with employers to create scalable testing programs that support business continuity.
Practical Prevention Tips
To reduce your risk of COVID-19 infection:
- Stay current with recommended vaccines
- Wash hands frequently
- Improve indoor ventilation
- Wear a mask in crowded indoor settings when appropriate
- Test when symptoms develop
- Stay home when sick
These measures continue to be effective regardless of the variant in circulation.
Should You Be Worried About BA.3.2?
The emergence of BA.3.2 is a reminder that SARS-CoV-2 continues to evolve. However, current evidence does not suggest that the Cicada variant is causing more severe disease than other Omicron descendants.
The most sensible response is preparedness—not panic.
By staying informed, testing when needed, and using trusted laboratory services, individuals and organizations can continue to manage COVID-19 effectively.
Why Choose My Care Labs for COVID Testing?
My Care Labs is a trusted diagnostic partner for patients, employers, and healthcare providers.
We Offer:
- Fast, accurate laboratory testing
- Walk-in convenience
- Insurance and affordable cash-pay options
- Mobile testing services
- Group and B2B testing solutions
- Experienced support team
Our mission is to make high-quality testing simple, accessible, and dependable.
Final Thoughts
BA.3.2 (“Cicada”) is a newly monitored Omicron subvariant with numerous mutations, but current data suggest it poses a low additional public health risk compared with other circulating strains.
COVID testing remains one of the best tools for protecting yourself and your community.
At My Care Labs, we are here to help with fast and reliable COVID-19 testing services for individuals, families, employers, and healthcare providers.